Expensive, newer therapies and a lack of pediatric data are roadblocks to advancing treatment for pediatric atopic dermatitis ...

Eichenfield said that depending on severity, atopic dermatitis treatment is begun right away in these younger patients ...

Determining a biologic's duration of use to treat pediatric atopic dermatitis has several factors, according to Lawrence ...

The 2025 Fall Clinical Dermatology Conference will be held in Las Vegas, Nevada, from Oct. 23 to 26. Eichenfield will present ...

There are some 40 interleukins that play a wide variety of roles in inflammation and the body’s immune response, some of them hitting the accelerator and others tapping the brakes. When it comes to ...

Mona Shahriari, M.D., dermatologist at Central Connecticut Dermatology and an associate clinical professor at Yale School of Medicine discusses the highlights of her session called ‘Seeing Clearly: A ...

Nearly 1 in 10 U.S. adults report having physician-diagnosed chronic head eczema, according to findings from a ...

The use of interleukin (IL)-23 inhibitors plays an important role in treating patients with psoriasis, as well as in treating ...

Unlike existing treatments that block individual cytokines such as IL-4, IL-13 or IL-31, therapies targeting the OX40 pathway ...

Shawn Kwatra, M.D., Joseph W. Burnett endowed professor and chair of dermatology at the University of Maryland School of ...

New clinical data demonstrate Zoryve's effectiveness in treating atopic dermatitis, reducing sleep disruptions and maintaining disease control with minimal adverse events across all ages.

The median annual net price of drugs launched from 2022 to 2024 increased by 51%, according to a new analysis from the ...